$IBIO Income Statement | Understand Stock

$IBIO

$0.71 -$0.01 (1.5%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Revenues
Cost of goods sold
Gross profit
Revenue
Operating expenses:
Research and development
General and administrative
Impairment of indefinite-lived intangible asset
Total operating expenses
Operating loss
Other income (expense):
Interest income
Loss on sales of debt securities
Royalty income
Forgiveness of note payable and accrued interest - SBA loan
Other
Gain on sale of intellectual property
Interest expense
Total other income

Net loss from continuing operations
Net loss attributable to noncontrolling interest
Preferred stock dividends - iBio CDMO Tracking Stock
Loss from discontinued operations
Net loss available to iBio, Inc. stockholders
Net loss before income taxes
Income tax expense
Net loss
Other comprehensive loss - unrealized loss on debt securities
Other comprehensive income - foreign currency adjustment
Loss per common share attributable to iBio, Inc. stockholders - basic - continuing operations
Loss per common share attributable to iBio, Inc. stockholders - basic - discontinued operations
Other comprehensive loss - unrealized loss on on debt securities
Comprehensive loss
Loss per common share - basic
Loss per common share - diluted
Weighted-average common shares outstanding - basic
Weighted-average common shares outstanding - diluted

Comments